Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: History, methodology and applications.

Aspiration studies Gastrointestinal drug concentrations Intestinal absorption Intraluminal drug and formulation behavior Sampling technique

Journal

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982

Informations de publication

Date de publication:
01 Dec 2020
Historique:
received: 07 06 2020
revised: 12 08 2020
accepted: 16 08 2020
pubmed: 21 8 2020
medline: 22 6 2021
entrez: 21 8 2020
Statut: ppublish

Résumé

Fluid sampling from the gastrointestinal (GI) tract has been applied as a valuable tool to gain more insight into the fluids present in the human GI tract and to explore the dynamic interplay of drug release, dissolution, precipitation and absorption after drug product administration to healthy subjects. In the last twenty years, collaborative initiatives have led to a plethora of clinical aspiration studies that aimed to unravel the luminal drug behavior of an orally administered drug product. The obtained drug concentration-time profiles from different segments in the GI tract were a valuable source of information to optimize and/or validate predictive in vitro and in silico tools, frequently applied in the non-clinical stage of drug product development. Sampling techniques are presently not only being considered as a stand-alone technique but are also used in combination with other in vivo techniques (e.g., gastric motility recording, magnetic resonance imaging (MRI)). By doing so, various physiological variables can be mapped simultaneously and evaluated for their impact on luminal drug and formulation behavior. This comprehensive review aims to describe the history, challenges and opportunities of the aspiration technique with a specific focus on how this technique can unravel the luminal behavior of drug products inside the human GI tract by providing a summary of studies performed over the last 20 years. A section 'Best practices' on how to perform the studies and how to treat the aspirated samples is described. In the conclusion, we focus on future perspectives concerning this technique.

Identifiants

pubmed: 32818656
pii: S0928-0987(20)30305-5
doi: 10.1016/j.ejps.2020.105517
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

105517

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Patrick Augustijns (P)

Drug delivery & Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven Herestraat 49, box 921, 3000 Leuven, Belgium.

Maria Vertzoni (M)

Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Greece.

Christos Reppas (C)

Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Greece.

Peter Langguth (P)

Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz 55131, Germany.

Hans Lennernäs (H)

Department of Pharmaceutical Biosciences and Technology, Uppsala University, Box 580, 751 23 Uppsala, Sweden.

Bertil Abrahamsson (B)

Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca Gothenburg, 431 83 Mölndal, Sweden.

William L Hasler (WL)

Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109, USA.

Jason R Baker (JR)

Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109, USA.

Tim Vanuytsel (T)

Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.

Jan Tack (J)

Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.

Maura Corsetti (M)

NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK.

Marival Bermejo (M)

Department Engineering Pharmacy Section, Miguel Hernandez University, San Juan de Alicante, 03550 Alicante, Spain.

Paulo Paixão (P)

Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal.

Gordon L Amidon (GL)

Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.

Bart Hens (B)

Drug delivery & Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven Herestraat 49, box 921, 3000 Leuven, Belgium. Electronic address: bart.hens@kuleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH